Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MACI with or without PRP for knee osteochondral injury
ChiCTR2300073094Phase 4Completed
- Sponsor
- The Third Medical Center of the Chinese People's Liberation Army General Hospital
- Start
- Jan 2016
- Modality
- Small Molecules, Cell Therapies, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of biomimetic cartilage matrix + autologous chondrocytes, platelet-rich plasma and glucosamine sulphate in Knee cartilage injury and osteochondral defect (OCD) (3 arms), sponsored by The Third Medical Center of the Chinese People's Liberation Army General Hospital. Primary endpoint: Knee KOOS score. Started Jan 2016; status: completed.
02
Drugs
biomimetic cartilage matrix + autologous chondrocytesplatelet-rich plasmaglucosamine sulphate
03
Conditions
Knee cartilage injuryosteochondral defect (OCD)
Beyond the preview
Go deeper on ChiCTR2300073094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300073094.